previously recognized as handset loss will be reallocated between device sales and service revenue weighted by fair market values of the handset price and full-contract price plan. As a result, device sales
(MB) For the three-month period 2018 2017 YoY % Q4/2018 Q4/2017 YoY % Total Sales and Services revenue 1,050.08 1,039.90 10.18 0.98% 4,220.99 4,308.04 (87.05) (2.02%) Raw water revenue 588.09 566.33
increased by Baht 272 million as a result of the increased revenue which followed the rise in availability rate from 40% in Q4/2018 to 99% in Q1/2019 due to no major overhaul. In addition, the cost of sales
performance according to consolidated financial statement For the three-month period (April 1, 2019 – June 30, 2019) Unit : Million Baht 2019 2018 Revenue from sales and rendering of services (excluding fuel
98.71 16.71% 101.52 20.86% (2.81) (2.77) Other income 0 0% 3.86 0.79% (3.86) (100) Cost of sales 8.22 1.39% 11.07 2.28% (2.86) (25.80) Administrative expenses 59.30 10.04% 48.76 10.02% 10.54 21.61
previous year. This came from decreasing in services revenue whereas sales revenues from medical devices still increased. Revenues from sales and services of EFORL and its subsidiaries in Q3/2018 increased
2.8% Revenue from finance lease under power purchase agreement 95.3 102.4 104.5 2.1% 9.7% 197.6 206.9 4.7% Cost of sales and services (1,174.0) (1,274.4) (1,191.7) (6.5%) 1.5% (2,323.4) (2,466.2) 6.1
decreased from the same period last year more than 20% as follows: 1. Operating Results Revenue In 2017, the Company’s revenue from sales was Baht 1,833.06 million decreased by Baht 221.29 million or 10.77
the 2018, the company and its subsidiaries have the total revenue from sales in amount of Baht 10,249.4 million which is decreasing from the 2017 at equivalence of Baht 2,060.1 million, about 17%. These
the Q2/2019, the company and its subsidiaries have the total revenue from sales in amount of Baht 2,406.0 million which is decreasing from the 2018 at equivalence of Baht 384.4 million, about 14%. These